Sinonasal disease, including current symptoms of allergic rhinitis
Asthma exacerbation or an upper respiratory viral infection within the previous six weeks
Current or concomitant use of oral steroids, monoclonal antibodies or nasal sprays
Neutralising antibodies to rhinovirus (RV)-16
Clinically significant diseases other than asthma which, in the opinion of the investigator, may either put the patient at risk because of participation in the study, influence the results of the study, an/or the patient's ability to take part in it
Inability to understand written or verbal information in English
For healthy control group:
As for Asthma group and in addition:
History of asthma
Clareo Health | Early Antiviral Responses to Rhinovirus Infection in Asthma
